MultiPlan Corporation Investors With Significant Losses Encouraged To Contact Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of MultiPlan Corporation (“MultiPlan” or the “Company”) (NYSE: MPLN) to determine whether the Company engaged in securities fraud or other unlawful business practices.
INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, THE SECURITIES OF MULTIPLAN CORPORATION AND SUFFERED SIGNFICANT LOSSES ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT KEVIN CAULEY, DIRECTOR, BUSINESS DEVELOPMENT, (215) 792-6676, EXT. 802, [email protected], [email protected], TO DISCUSS THE SECURITIES INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
Muddy Waters Research published a report (“MultiPlan: Private Equity Necrophilia Meets The Great 2020 Money Grab”), which, among other things, stated that “MPLN is in the process of losing its largest client, UnitedHealthcare (‘UHC’). UHC has formed a competitor to [MultiPlan] that offers significantly lower prices and fewer conflicts of interest. The competitor is called Naviguard.”
Muddy Waters Research also reported that MultiPlan “. . . was already in financial decline, and its financial statements were engineered to obscure this existing deterioration.” Further, according to Muddy Waters Research, “. . . in 2018, [MultiPlan] released revenue reserves, dropping them from approximately 30% to 10% of revenue, which . . . enabled [MultiPlan] to show 2018 EBITDA growth amid shrinking sales.”
On this news, MultiPlan’s stock dropped $1.72 per share, or 19.7%, to close at $7.01 on November 11, 2020.